317 related articles for article (PubMed ID: 21076300)
21. Role of biobanking in urology: a review.
Chalfin HJ; Fabian E; Mangold L; Yeater DB; Pienta KJ; Partin AW
BJU Int; 2016 Dec; 118(6):864-868. PubMed ID: 27469064
[TBL] [Abstract][Full Text] [Related]
22. About the new significance and the contingent meaning of biological material and data in biobanks.
Mayrhofer MT
Hist Philos Life Sci; 2013; 35(3):449-67. PubMed ID: 24779112
[TBL] [Abstract][Full Text] [Related]
23. [Biobanks as the basis for developing biomedicine: Problems and prospects].
Reznik ON; Kuzmin DO; Reznik AO
Mol Biol (Mosk); 2017; 51(5):761-771. PubMed ID: 29116062
[TBL] [Abstract][Full Text] [Related]
24. Novel clinico-genome network modeling for revolutionizing genotype-phenotype-based personalized cancer care.
Roukos DH
Expert Rev Mol Diagn; 2010 Jan; 10(1):33-48. PubMed ID: 20014921
[TBL] [Abstract][Full Text] [Related]
25. The importance of biobanking in cancer research.
Castillo-Pelayo T; Babinszky S; LeBlanc J; Watson PH
Biopreserv Biobank; 2015 Jun; 13(3):172-7. PubMed ID: 26035006
[TBL] [Abstract][Full Text] [Related]
26. Biobanking in the Twenty-First Century: Driving Population Metrics into Biobanking Quality.
Roberts JN; Karvonen C; Graham K; Weinfeld M; Joy AA; Koebel M; Morris D; Robson PJ; Johnston RN; Brockton NT
Adv Exp Med Biol; 2015; 864():95-114. PubMed ID: 26420616
[TBL] [Abstract][Full Text] [Related]
27. Nordic biological specimen banks as basis for studies of cancer causes and control--more than 2 million sample donors, 25 million person years and 100,000 prospective cancers.
Pukkala E; Andersen A; Berglund G; Gislefoss R; Gudnason V; Hallmans G; Jellum E; Jousilahti P; Knekt P; Koskela P; Kyyrönen PP; Lenner P; Luostarinen T; Löve A; Ogmundsdóttir H; Stattin P; Tenkanen L; Tryggvadóttir L; Virtamo J; Wadell G; Widell A; Lehtinen M; Dillner J
Acta Oncol; 2007; 46(3):286-307. PubMed ID: 17450464
[TBL] [Abstract][Full Text] [Related]
28. The tissue is the issue: personalized medicine for non-small cell lung cancer.
Hirsch FR; Wynes MW; Gandara DR; Bunn PA
Clin Cancer Res; 2010 Oct; 16(20):4909-11. PubMed ID: 20926402
[TBL] [Abstract][Full Text] [Related]
29. The Organization of European Cancer Institute Pathobiology Working Group and its support of European biobanking infrastructures for translational cancer research.
Riegman PH; de Jong BW; Llombart-Bosch A
Cancer Epidemiol Biomarkers Prev; 2010 Apr; 19(4):923-6. PubMed ID: 20332270
[TBL] [Abstract][Full Text] [Related]
30. The role of nanobiotechnology in the development of personalized medicine.
Jain KK
Med Princ Pract; 2011; 20(1):1-3. PubMed ID: 21160206
[No Abstract] [Full Text] [Related]
31. Biobanking: sample acquisition and quality assurance for 'omics' research.
Yüzbaşıoğlu A; Özgüç M
N Biotechnol; 2013 Mar; 30(3):339-42. PubMed ID: 23183539
[TBL] [Abstract][Full Text] [Related]
32. [Personalized medicine in oncology: from hope to reality].
Besse B; Soria JC
Rev Prat; 2012 Feb; 62(2):245-6. PubMed ID: 22408877
[No Abstract] [Full Text] [Related]
33. An online tool for improving biospecimen data element reporting.
Cheah S; Dee S; Cole A; Matzke L; O'Donoghue S; Watson PH
Biopreserv Biobank; 2012 Dec; 10(6):501-10. PubMed ID: 24845136
[TBL] [Abstract][Full Text] [Related]
34. Translational proteomics: what can you do for true patients?
Belda-Iniesta C; de Castro J; Perona R
J Proteome Res; 2011 Jan; 10(1):101-4. PubMed ID: 20977278
[TBL] [Abstract][Full Text] [Related]
35. Cancer-related forecast biomarkers: a topic in focus of the Worldwide Innovative Network in Personalized Cancer Medicine (WIN).
Schmitt M; Lazar V
Bioanalysis; 2010 May; 2(5):851-3. PubMed ID: 21083216
[No Abstract] [Full Text] [Related]
36. The 2010 Health Care Reform Act: a potential opportunity to advance cancer research by taking cancer personally.
Dalton WS; Sullivan DM; Yeatman TJ; Fenstermacher DA
Clin Cancer Res; 2010 Dec; 16(24):5987-96. PubMed ID: 21169252
[TBL] [Abstract][Full Text] [Related]
37. Tumor heterogeneity as the foundation of personalized cancer treatment.
Schilsky RL
Semin Oncol; 2011 Apr; 38(2):171-2. PubMed ID: 21421107
[No Abstract] [Full Text] [Related]
38. Personalized medicine in oncology: tailoring the right drug to the right patient.
Jiang Y; Wang M
Biomark Med; 2010 Aug; 4(4):523-33. PubMed ID: 20701441
[TBL] [Abstract][Full Text] [Related]
39. Procurement, Storage, and Use of Blood in Biobanks.
Perry JN; Jasim A; Hojat A; Yong WH
Methods Mol Biol; 2019; 1897():89-97. PubMed ID: 30539437
[TBL] [Abstract][Full Text] [Related]
40. A legal framework for biobanking: the German experience.
Simon J; Paslack R; Robienski J; Cooper DN; Goebel JW; Krawczak M
Eur J Hum Genet; 2007 May; 15(5):528-32. PubMed ID: 17356548
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
